Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 5(3): e9819, 2010 Mar 23.
Article in English | MEDLINE | ID: mdl-20352108

ABSTRACT

Cystatin C (CysC) expression in the brain is elevated in human patients with epilepsy, in animal models of neurodegenerative conditions, and in response to injury, but whether up-regulated CysC expression is a manifestation of neurodegeneration or a cellular repair response is not understood. This study demonstrates that human CysC is neuroprotective in cultures exposed to cytotoxic challenges, including nutritional-deprivation, colchicine, staurosporine, and oxidative stress. While CysC is a cysteine protease inhibitor, cathepsin B inhibition was not required for the neuroprotective action of CysC. Cells responded to CysC by inducing fully functional autophagy via the mTOR pathway, leading to enhanced proteolytic clearance of autophagy substrates by lysosomes. Neuroprotective effects of CysC were prevented by inhibiting autophagy with beclin 1 siRNA or 3-methyladenine. Our findings show that CysC plays a protective role under conditions of neuronal challenge by inducing autophagy via mTOR inhibition and are consistent with CysC being neuroprotective in neurodegenerative diseases. Thus, modulation of CysC expression has therapeutic implications for stroke, Alzheimer's disease, and other neurodegenerative disorders.


Subject(s)
Autophagy , Cystatin C/metabolism , Neurons/metabolism , TOR Serine-Threonine Kinases/antagonists & inhibitors , Adenine/analogs & derivatives , Adenine/metabolism , Animals , Apoptosis Regulatory Proteins/metabolism , Beclin-1 , Cell Line , Colchicine/pharmacology , Enzyme Inhibitors/pharmacology , Lysosomes/metabolism , Mice , Neurodegenerative Diseases/metabolism , Oxidative Stress , Rats , Rats, Sprague-Dawley , Staurosporine/pharmacology , TOR Serine-Threonine Kinases/metabolism , Tubulin Modulators/pharmacology
2.
J Hypertens ; 27(3): 587-98, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19330919

ABSTRACT

BACKGROUND: The kidney's role in the pathogenesis of salt-induced hypertension remains unclear. However, it has been suggested that inherited morphological renal abnormalities may cause hypertension. We hypothesized that functional, not morphological, derangements in Dahl salt-sensitive rats' kidneys cause NaCl retention that leads to hypertension accompanied by renal pathologic changes and proteinuria. METHOD: We studied hemodynamic, renal morphologic, and biochemical differences in Dahl salt-resistant and Dahl salt-sensitive rats fed low (0.05-0.23% NaCl) or elevated (1% NaCl) salt diets. RESULTS: We found similar hemodynamics, equal numbers of glomeruli, normal renal medullary interstitial cells and their osmiophilic granules, and cortical morphology in normotensive Dahl salt-resistant and Dahl salt-sensitive rats fed low dietary salt. Furthermore, aldosterone secretion, caused by angiotensin II infusion in normotensive rats fed 0.23% NaCl, was significantly less in Dahl salt-sensitive than Dahl salt-resistant rats. Increasing NaCl to 1% caused renal vasoconstriction without changing cyclic GMP excretion in Dahl salt-sensitive rats; in Dahl salt-resistant rats, cyclic GMP increased markedly and renal vascular resistance remained unchanged. On 1% NaCl for 9 months, Dahl salt-sensitive rats developed marked hypertension, severe renal vasoconstriction, glomerulosclerosis, tubulointerstitial abnormalities, and marked proteinuria; hypertension resulted from increased total peripheral resistance, as occurs in essential hypertensive humans. No hemodynamic or renal pathologic changes occurred in Dahl salt-resistant rats, and proteinuria was minimal. CONCLUSION: We conclude that renal functional, not morphological, abnormalities cause salt sensitivity in Dahl rats.


Subject(s)
Hypertension/etiology , Kidney/metabolism , Sodium Chloride, Dietary/adverse effects , Aldosterone/metabolism , Angiotensin II/adverse effects , Animals , Blood Pressure/drug effects , Cyclic GMP/metabolism , Diastole/drug effects , Dose-Response Relationship, Drug , Fibrosis/chemically induced , Fibrosis/pathology , Glomerulosclerosis, Focal Segmental/chemically induced , Glomerulosclerosis, Focal Segmental/metabolism , Glomerulosclerosis, Focal Segmental/pathology , Hemodynamics , Hypertension/physiopathology , Kidney/pathology , Kidney Glomerulus/pathology , Kidney Glomerulus/ultrastructure , Kidney Medulla/cytology , Kidney Medulla/ultrastructure , Organ Size/drug effects , Proteinuria/chemically induced , Proteinuria/metabolism , Proteinuria/physiopathology , Rats , Rats, Inbred Dahl , Sodium/blood , Sodium/metabolism , Sodium Chloride, Dietary/metabolism , Systole/drug effects , Time Factors , Vascular Resistance/drug effects , Vasoconstriction/drug effects
3.
Gynecol Oncol ; 96(1): 249-53, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15589611

ABSTRACT

BACKGROUND: Large cell variant of small cell carcinoma hypercalcemic type (SCC-HT) is extremely rare. All reported cases involved an ovary, and one with primary peritoneal origin has not been described. Also, convincing neuroendocrine granules have not been illustrated. CASE: A 35-year-old woman underwent an exploratory laparotomy for leiomyomas. Intraoperative impression of peritoneal carcinomatosis was confirmed on frozen section. TAH/BSO, debulking/omentectomy followed. The tumor was present on the pelvic/abdominal peritoneum. The normal-sized ovaries were free of tumor grossly. The tumor had features of large cell variant of SCC-HT, described in the ovary. Furthermore, unequivocal neuroendocrine granules were present. The patient received standard chemotherapy for SCC. At 22 months she is NED. CONCLUSION: SCC-HT should be considered in the differential diagnosis of primary neoplasms of the peritoneum.


Subject(s)
Carcinoma, Small Cell/pathology , Hypercalcemia/pathology , Peritoneal Neoplasms/pathology , Adult , Carcinoma, Small Cell/blood , Carcinoma, Small Cell/surgery , Carcinoma, Small Cell/ultrastructure , Female , Humans , Peritoneal Neoplasms/blood , Peritoneal Neoplasms/surgery , Peritoneal Neoplasms/ultrastructure
4.
J Neurosci Methods ; 132(1): 1-7, 2004 Jan 15.
Article in English | MEDLINE | ID: mdl-14687669

ABSTRACT

In classical chromatolysis, Nissl bodies are initially lost centrally with subsequent progression to the periphery of the neuron. Peripheral chromatolysis has the opposite pattern; it is less common and more difficult to produce. We describe a new method for producing peripheral chromatolysis in neurons of trigeminal ganglia and dorsal root ganglia that requires only injection of large doses of lithium chloride (LiCl) for two, three or four consecutive daily doses. This method may be useful for elucidating the intraneuronal mechanisms that control the location and structure of the Nissl bodies.


Subject(s)
Adjuvants, Immunologic/toxicity , Ganglia, Spinal/drug effects , Lithium Chloride/toxicity , Neurons/drug effects , Nissl Bodies/drug effects , Trigeminal Ganglion/drug effects , Animals , Axotomy , Female , Ganglia, Spinal/pathology , Ganglia, Spinal/ultrastructure , Methods , Microscopy, Electron/methods , Neurons/pathology , Neurons/ultrastructure , Nissl Bodies/pathology , Rats , Rats, Inbred Lew , Trigeminal Ganglion/pathology , Trigeminal Ganglion/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...